Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B12-trafficking proteins ABCD4 and LMBD1
Victoria Fettelschoss(University Children's Hospital Zurich), Matthias R. Baumgartner(University Children's Hospital Zurich), Beat Bornhäuser(University Children's Hospital Zurich), D. Sean Froese(University of Zurich), Corinne Sagné(Centre National de la Recherche Scientifique), Seraina Lutz(University Children's Hospital Zurich), Terttu Suormala(Johns Hopkins University), Patricie Burda(University Children's Hospital Zurich), Brian Fowler(University of Pittsburgh Medical Center), Nicolas Pietrancosta(Centre National de la Recherche Scientifique), Bruno Gasnier(Centre National de la Recherche Scientifique), Corinne De Laet(Areté Associates (United States)), David Coelho(Inserm)
Cited by 37
Related Papers
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
|The American Journal of Human Genetics|2007|449
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Vitamin B<sub>12</sub>, folate, and the methionine remethylation cycle—biochemistry, pathways, and regulation
|Journal of Inherited Metabolic Disease|2019|434